Product category:
Laboratory and scientific exhibitions and conferences
News Release from: Deutsche Messe | Subject: Biotechnica
Edited by the Laboratorytalk Editorial
Team on 07 June 2007
Biotechnica moves to annual timing in
Hannover
Decision to move to an annual timeslot was reached after extensive market analysis, and with the full backing of the Biotechnica exhibitors' committee, which had unanimously voted for the new rhythm
Europe's biggest biotechnology trade fair, Biotechnica, will now be taking place every year at its home base in Hannover, Germany So following Biotechnica 2007 (9-11 October), Hannover will be playing host to the international biotech industry again in 2008 and every year thereafter
This article was originally published on Laboratorytalk on 9 May 2007 at 8.00am (UK)
Related stories
Biotechnica goes to America
Partnership creates a global meeting-place for companies engaged in the core pharmaceutical and biotech sectors, including process development and R+D through services, manufacturing and packaging
Biotechnica 2007 looks to industrial applications
Europe's leading biotechnology show is about to open its doors once again - the international trade fair Biotechnica will be taking place at the Hannover Exhibition Center from 9 to 11 October 2007
"The industry's key players want to have a major European trade fair every year, rather than a succession of smaller events.
"And with Biotechnica we can give the industry the flagship European event it is looking for", says Deutsche Messe board member Stephan Kuhne.
"At the same time we are expanding the conference programme, which will make the show even more appealing than ever.
Further reading
Biotechnica 2007 hosts business partnering forum
The aim of the event is to make it easier for companies to set outside their operational routines and more easily join forces and pool their expertise
Three finalists named for Biotechnica Award 2006
International jury has nominated biotechnology companies Amaxa from Germany, Intercell from Austria, and Genmab from Denmark for the award, which is worth a total of 40,000 euros in prize money
Business development for biotech and pharma
Business development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deals per year and much more than that in the value of mergers and acquisitions
"Having a regular annual platform will also make networking easier and provide the continuity that high-powered conferences need".
Biotechnica is regarded as the leading event of the year for the European biotech industry, covering all sectors of biotechnology in depth - from basic biotechnology research, equipment, bioinformatics and services to the five principal areas of application - pharmaceuticals and medicine, industry, nutrition, agriculture and the environment.
But Biotechnica is far more than just a trade show and exhibition.
With its many conventions and specialised events it offers exhibitors and visitors a central platform for knowledge transfer.
About 900 companies from more than 30 countries are expected to take part in the exhibition.
One of the highlights of Biotechnica is the much expanded conference programme.
Distinguished speakers from industry, the scientific community and government will be reporting on the latest developments in the biotech industry.
In addition, the show is hosting some 20 high-level international conferences and seminars, including the German Biotechnology Days (formerly the BMBF Biotechnology Days), the Conference for Regenerative Medicine and the Vaccine Development Days.
Biotechnica Partnering: the purpose of this new matchmaking event is to bring together companies that would not normally have contact with each other in their day-to-day business dealings - a global pharmaceutical giant and a young biotech start-up, for instance.
The main focus of the Biotechnica partnering event is the emerging field of medicine known as 'drug-device combination therapy'.
Among the innovative products on display are tiny devices implanted in blood vessels.
Here they secrete the drug directly where the disease is active.
European Biotechnica Award: this is regarded as the world's most exciting competition aimed at encouraging and motivating young biotech companies.
The prize money has been increased by 60,000euros this year to a princely 100,000euros.
The finalists will be chosen by an international jury of experts.
The switch to a regular annual schedule will significantly enhance the appeal of Biotechnica.
The majority of exhibitors voted in favour of making the show the foremost industry gathering in Europe - on the basis of a broader concept that includes more international conferences and seminars as well as the new partnering event.
The effect of this will be to significantly increase the appeal of the show to potential exhibitor and visitor target groups, particularly in the market populated by core biotechnology companies.
At the same time the leading trade fair for the biotech industry is also repositioning itself on the global stage.
This summer Biotechnica is celebrating its debut in China with a new overseas trade show: the first Biotech China opens its doors to the public in Shanghai from 4-6 July 2007.
The new show gives exhibiting companies an ideal platform for establishing new business contacts in Asia.
It enables Western firms to secure a foothold in a market with vast growth potential.
In the USA plans are being finalised for a joint venture involving Biotechnica and the US trade fair Interphex.
So from 26-28 March 2008 Biotechnica America and Interphex will take place in parallel at the Pennsylvania Convention Center in Philadelphia, effectively pooling their combined expertise.
This will create a new international meeting place for pharmaceutical and biotech companies.
The proposed themes of the joint trade show and congress event are biotech engineering, pharma manufacturing and processing, and equipment and services.
"This means that Biotechnica is the only industry platform to have a presence in the world's three most important biotech regions: Europe, North America and the booming growth market of Asia", explains Deutsche Messe board member Kuhne. Request a free brochure from Deutsche Messe ...
"Biotechnica is busily building bridges for international business.".
• Deutsche Messe: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
